Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampic
Clinical trial NCT04437836 · COMPLETED
Trial details
- NCT number
- NCT04437836
- Sponsor
- Kilimanjaro Clinical Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2022-06-30
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.